Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study

Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study

Author Batista, José Gomes Autor UNIFESP Google Scholar
Soares-jr, José Maria Autor UNIFESP Google Scholar
Maganhin, Carla Cristina Autor UNIFESP Google Scholar
Simões, Ricardo Santos Google Scholar
Tomaz, Geraldez Google Scholar
Baracat, Edmund Chada Autor UNIFESP Google Scholar
Institution Universidade Federal de São Paulo (UNIFESP)
Federal University of Paraíba Obstetrics and Gynecology Department
Universidade de São Paulo (USP)
Language English
Sponsor Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Federal University of Sao Paulo
Federal University of Paraiba
Date 2012-01-01
Published in Clinics. Faculdade de Medicina / USP, v. 67, n. 3, p. 283-287, 2012.
ISSN 1807-5932 (Sherpa/Romeo, impact factor)
Publisher Faculdade de Medicina / USP
Extent 283-287
Origin http://dx.doi.org/10.6061/clinics/2012(03)14
Access rights Open access Open Access
Type Article
Web of Science ID WOS:000302362900014
SciELO ID S1807-59322012000300014 (statistics in SciELO)
URI http://repositorio.unifesp.br/handle/11600/6811

Show full item record




File

Name: S1807-59322012000300014.pdf
Size: 1.113Mb
Format: PDF
Description:
Open file

This item appears in the following Collection(s)

Search


Browse

Statistics

My Account